“We estimate 1Q18 adjusted EBITDA was $297.6 million (up 5% y-o-y and up 17% q-o-q) on the back of higher FY17 average market share of 40% for both the VIP and mass markets,” says lead analyst Cezzane See in a flash note on Thursday.
SINGAPORE (Apr 27): CIMB Research expects Genting Singapore (GENS) to report an estimated 5% year-on-year improvement in adjusted EBITDA for the 1Q ended March on the back of higher market share.
GENS is scheduled to announce its 1Q18 results after market close on May 10.
